Perseus Proteomics, Inc. (JP:4882) has released an update.
Perseus Proteomics Inc. experienced a year-on-year decline in its first-quarter financial performance, with net sales dropping to 20 million yen and a net loss of 219 million yen. The company’s financial position, however, shows an increase in total assets and net assets, with a shareholders’ equity ratio of 82.7% as of June 30, 2024. They have not announced a financial forecast for the fiscal year ending March 31, 2025, citing the difficulty of making rational predictions.
For further insights into JP:4882 stock, check out TipRanks’ Stock Analysis page.
